Glycoconjugate structure in upper gastrointestinal epithelium was studied using five lectins to determine the relationship between aberrant differentiation and glycoconjugate expression. Specimens of normal esophagus, stomach, and duodenum were examined and compared with specimens of columnar metaplasia in the esophagus (Barrett's esophagus) and specimens of adenocarcinoma of the esophagus and stomach. Specific terminal glycoconjugate structures were found for the esophagus, stomach, and duodenum. Minor differences were found between the antral and fundic gland mucosae, reflecting their respective cell populations. In biopsies of Barrett's esophagus, gastric-type columnar metaplasia expressed glycoconjugates indistinguishable from those in the normal stomach. In specialized-type columnar metaplasia, a more restricted expression of glycoconjugates was seen resembling the normal duodenum. The presence of low grade dysplasia in Barrett's esophagus associated with adenocarcinoma had no impact on glycoconjugate expression. However, a distinctive difference in glycosylation was seen in high grade dysplasia of the columnar-lined esophagus and in adenocarcinoma of the esophagus and stomach. Barrett's esophagus is a morphological mosaic in which the glycoconjugate expression resembles that seen in the normal stomach and duodenum. However, in high grade dysplasia and carcinoma, variable deletion of glycoconjugate expression can be found.
Introduction
Glycoconjugates are abundantly expressed in gastrointestinal epithelium, and play a central role in a wide range of cellular behavior (1) . Much of the heterogeneity expressed among glycoconjugates is due to structural variations in the carbohydrate portion of the molecule (2) . Specifically, although only five different monosaccharide residues may be found in mammalian gastrointestinal mucins,' an extremely rich range of diver-sity may be generated by differences in the carbohydrate sequences and anomeric linkages between adjacent sugar residues (3, 4) .
Certain antigenic structures may be recognized in glycoproteins that are associated with the process of normal cellular differentiation (5, 6) . The mechanism for this is in part due to differential expression of glycosyltransferase activities during the process of differentiation (6) . Different forms of mucin are expressed not only as a function of location within the gastrointestinal tract (7, 8) , but also in association with the process of differentiation (9) . In addition, a specific form of mucin not seen in normal colon is expressed in benign and malignant colonic neoplasms, which may be detected using lectin histochemical techniques (9, 10) . Gastrointestinal mucins have attracted interest because their structural diversity reflects modifications in glycoprotein synthesis and processing that accompany cellular differentiation, neoplasia, inflammatory bowel disease (1 1), and possibly peptic ulcer disease (12) .
A paradigm of aberrant cellular differentiation occurring in response to chronic injury is the phenomenon of columnar metaplasia in the esophagus in the setting of chronic gastroesophageal reflux (Barrett's esophagus). In this disease process, squamous epithelium is progressively replaced by columnar epithelium in a cephalad direction, and an increased risk for the development of adenocarcinoma is observed (13) . This epithelium has been characterized histologically ( 14) , in terms of cell kinetics (15) , and histochemically (16) (17) (18) . However, traditional histochemical techniques are limited in their ability to define the structure of mucins.
We have previously utilized fluorescent lectins to characterize differences in structure that occur with differentiation and in a variety of neoplastic and preneoplastic lesions in the colon (19, 20) . Lectins Lectin labeling. 4-,um paraffin-embedded sections were used for these studies. Each section of tissue was deparaffinized in xylene and rehydrated through serial alcohol solutions to PBS. The tissues were labeled with FITC-conjugated lectin in a concentration of 100 /g/ml.
50 Ml of lectin was applied to the tissue section, incubated for 20 min, and washed off with PBS. The tissue sections were then mounted in gelvatol (Montsanto Co., St. Louis, MO) and the slides were examined with a Zeiss epifluorescence microscope.
The lectins used and their corresponding hapten sugars are listed in Table I . The specificity of binding was documented by specific inhibition in the presence of 200 mM hapten sugar. The lectins were obtained commercially from Vector Laboratories (Burlingame, CA) and E-Y Laboratories (San Mateo, CA).
Each of the lectins was applied to each of the 123 specimens collected. Because of the obvious morphological configuration of each specimen, it was not possible to blind the fluorescence microscopist to the identity of the tissues. However, the fluorescence microscopist was blinded to the clinical information regarding each case, and the histopathologist was blinded to the lectin-binding findings while assigning the tissues to the various pathological categories. Prior investigation using this technique has demonstrated a high degree of intra-and interobserver reproducibility (23, 24) .
The binding of fluorescent lectins to tissues was scored from 0 to 3+. Zero indicated negative staining, and the most intense degree of labeling was assigned a score of 3+. Scores of 1+ and 2+ referred to weak and intermediate levels ofbinding, respectively. The fluorescence microscopist identified distinct components ofthe mucosa within each biopsy and scored them independently. One microscopist scored all of the specimens (Dr. Shimamoto). Schematic representations indicate the components that were identified and scored individually. This method permitted the individual scoring of glycoconjugates that were intracellular, localized within a goblet cell theca, or secreted. It was not possible to clearly distinguish whether the labeling that occurred along the luminal surface of an epithelial cell represented cell membrane labeling or the presence of secreted glycoconjugates (e.g., mucus) that had become adherent to the luminal surface ofthe cell. Labeling in this region was referred to as membrane-associated. This labeling was recorded independently of secreted mucus that was clearly distinguishable from the membrane-associated labeling.
Glycoconjugate expression was recorded in terms of region within the upper gastrointestinal tract, pathological diagnosis, lectin used, cell population within the biopsy, and intensity of labeling. 
Results
Esophagus. Fig. 1 a is a schematic representation ofsquamous esophageal mucosa. The superficial and basal portions of the epithelium have been scored separately. Fig. 1 b is a bar graph in which the data are recorded in terms ofthe percentage ofthe biopsies labeled with each of the lectins in each mucosal zone. The height of the bar indicates the percentage of biopsies labeled by each of the lectins. In the case of esophageal mucosa, 80-90% of the biopsies showed no labeling with the panel of lectins, most of the labeling was weak, and there were no important differences in labeling between the superficial and basal portions of the epithelium.
Proximal stomach:fundic gland mucosa. Fig. 2 a is a schematic representation of the fundic gland mucosa, in which various portions of the mucosa have been independently evaluated. Fig. 2 Fig. 1 . Mem., Membrane-associated labeling, i.e., that on the cell membrane adjacent to the lumen or secreted mucus adherent to the luminal surface; Sur. ep., labeling in the cytoplasm of the surface epithelium and pit epithelium; P.C.
zone, labeling of the parietal cell zone, which is in the upper half of the deep fundic gland; C.C. zone, labeling of the chief cell zone, which is in the lower portion of the fundic gland mucosa; Sec. muc., labeling of secreted mucus. The individual lectins are indicated along the bottom of the graph as described in Fig. 1 Gastric-type columnar metaplasia. Fig. 3 a is a schematic representation of regions evaluated in gastric-type columnar metaplasia in the esophagus. Fig. 3 b is a bar graph of the lectin-binding results in biopsies with exclusively gastric-type surface epithelium, or with major zones of it in the biopsies. The labeling patterns using s-WGA, UEA1, PNA, DBA, and LFA closely resembled those of the gastric antrum, with the exception of secreted mucus, which showed binding by s-WGA and UEA, in all cases.
Duodenum. Fig. 4 a is a schematic representation of the duodenal epithelium. Fig. 4 Figure 3 . Lectin labeling of epithelial glycoconjugates in gastric-type Barrett's epithelium (n = 27 specimens). Mem., Sur. ep., and Sec. muc. refer to lectin labeling in epithelial domains as defined in Fig.  2 . Gland, labeling in the underlying (deep) mucous glands. The bars and axes are as defined in Fig. 1 . Two differences were seen between glycoconjugates in specialized columnar epithelial metaplasia and those in normal duodenum. First, throughout the epithelium of specialized metaplasia, all ofthe tissues showed binding by UEA1 and 60% bound s-WGA, whereas none of these lectins labeled the surface or crypt epithelium in the normal duodenum. Secondly, in approximately half of the metaplastic tissues, the binding of LFA to goblet cell mucin was seen, a feature present in none of the normal tissues.
Dysplasia in Barrett's esophagus. Five biopsies of Barrett's esophagus not associated with esophageal cancer contained foci of cytological abnormalities that fell into the poorly defined category of "low grade dysplasia." Four of these were Figure 5 . Lectin labeling of epithelial glycoconjugates in specialized Barrett's epithelium (n = 25 specimens). Mem. and Sec. muc. refer to epithelial domains as defined in Fig. 1 . Sur. ep. in this figure refers to labeling in the surface, pit, and villous-type epithelium. G.C.M., Labeling of goblet cell mucin; Gland, labeling of glycoconjugates in the underlying mucous glands. The bars and axes are as described in Fig. 1. seen in gastric-type columnar metaplasia and one was in specialized-type metaplasia. When analyzed separately, these tissues had the same lectin labeling patterns as were seen in the other gastric-type and specialized-type metaplastic tissues without foci of low grade dysplasia, including labeling with the lectin LFA. Because of the small numbers and difficulty in making this diagnosis, these biopsies were not considered further as separate groups. Fig. 6 depicts the lectin labeling of glycoconjugates in high grade dysplasia in Barrett's epithelium from patients with adenocarcinoma of the esophagus. In these tissues, there was a complete loss of the expression of lectin-binding glycoconjugates in the superficial epithelium and the upper half of the glandular elements. Note the "normal" expression of binding sites for s-WGA, UEA1, PNA, and DBA in the deep mucous glands of this epithelium. The lectin LFA did not bind to any tissue in this group.
Esophageal adenocarcinoma. The labeling of the surface membrane or cytoplasmic glycoconjugates among the eleven moderately to well differentiated esophageal adenocarcinomas is depicted in Fig. 7 . Again, labeling by s-WGA was seen in all the tumors, whereas there were intermediate degrees of labeling with UEAI and PNA. Weak labeling by DBA was seen in only one tumor and no tumor bound LFA. Among the adenocarcinomas ofthe esophagus, most ofthe labeling occurred on the cell membrane that made up the lumenal perimeter of the malignant gland. Cytoplasmic labeling was much less promi- Figure 6 . High grade dysplasia in Barrett's epithelium (n = 8 specimens). Mem. and Sur. ep. in this bar graph refer to epithelial labeling domains as defined in Fig. 2 . Pit. ep. refers to labeling in the epithelium of the pits or crypts. Gland refers to labeling in deep mucous glands. The bars and axes are as described in Fig. 1. nent than in the gastric carcinomas, and labeling of secreted mucins was not seen.
For both benign and malignant tissues, there did not appear to be any differences in labeling related to the fixative, i.e., Bouin's or formalin.
Gastric adenocarcinoma. The labeling of cytoplasmic, cell surface membrane, and secreted glycoconjugates in moderately and well differentiated gastric adenocarcinomas is indicated in the left panel of Fig. 8 . In these four cancers, the binding of s-WGA, UEA1, and PNA to cytoplasmic, membrane-associated, and secreted glycoconjugates was prominent, whereas labeling by DBA and LFA was not seen. The right panel of Fig. 8 depicts lectin labeling in the eight poorly differentiated gastric adenocarcinomas. In this instance, s-WGA and PNA prominently labeled both the cell surface membrane and cytoplasm. In these poorly differentiated adenocarcinomas, no well-formed glands or secreted mucins were visualized. The labeling by UEA1 was absent among all the poorly differentiated tumors, which contrasted with the labeling seen in the moderately and well-differentiated gastric adenocarcinomas.
Nonneoplastic gastric mucosa was examined in eight specimens from four of the resected specimens of gastric cancer, and was found to have the same glycoconjugate expression as those gastric specimens from patients with Barrett's esophagus. and axes are as described in Fig. 1 . Labeling of glycoconjugates in poorly differentiated adenocarcinoma (PDAC) is depicted in the right bar graph (n = 8 specimens). Secreted glycoconjugates were not labeled in any of these specimens. The bars and axes are as described in Fig. 1 .
Metaplasia in the stomach and duodenum. Foci of intestinal metaplasia were encountered in three gastric biopsies. In all three there was an abrupt change in glycoconjugate expression from that typical of the stomach to that characteristic of duodenum. Fig. 9 is a photomicrograph that illustrates the parallel changes in morphology and glycoconjugate expression.
Similarly, one focus of gastric metaplasia was found in an otherwise normal specimen of duodenal mucosa. The binding of lectins to the metaplastic tissue underwent an abrupt change, and resembled that seen in gastric epithelium.
Discussion
The results indicate that the esophagus, stomach, and duodenum all have their characteristic "fingerprint" with respect to terminal glycosylation patterns as measured by the binding of lectins. Metaplastic tissues synthesize glycoconjugates true to the morphological configuration of the tissue, regardless of its anatomic location in the upper gastrointestinal tract. The development of low grade dysplasia is not accompanied by important changes in glycosylation, however high grade dysplasia and carcinoma have their own characteristic patterns of glycosylation, including a variable deletion of several terminal carbohydrate structures.
The normal stomach has prominent expression of structures that bind s-WGA (which recognizes n-acetylglucosamine [GlcNAc] residues), UEA, (which recognizes the alpha-linked fucose, such as that in the blood group 0 or H structure), and PNA (which recognizes the exposed disaccharide galactose beta 1,3 n-acetylgalactosamine, or the T-antigen). Structures recognized by DBA (which binds the terminal alpha-linked n-acetylgalactosamine in blood group Al) are more selectively expressed, and those binding LFA (sialic acid) are not seen. A review of the patients' blood types revealed that DBA labeled only biopsies from blood group A patients (data not presented). Although this is not surprising, it differs from the colon, in which DBA binds to colonic mucins from patients with all ABO blood types (8, 9 In spite of the morphological differences between the fundic and antral gland mucosae, only minor differences in glycoconjugate expression were seen, specifically the absence of binding sites for PNA and paucity of those for s-WGA in the chief cell zone in the lower portion of the fundic glands. This latter observation suggests a selective expression of glycoconjugates by chief cells. No change in the pattern of glycoconjugate expression was seen in the mucous neck cell region, which is thought to be the proliferative region of gastric epithelium (29) . The expression of different glycoconjugate structures throughout the crypt unit has been reported in the small intestine (1, 5) and colon (7, 9) , which may reflect either differentiation-dependent or other functionally dependent changes in glycosylation.
The duodenal mucosa differed from gastric mucosa with a marked reduction in lectin-binding sites in both the villus and crypt regions. Brunner's glands differed strikingly from the overlying epithelium in that glycoconjugates in the former were bound by s-WGA, UEA1, and PNA.
In metaplastic epithelium, differentiated tissue is found in an inappropriate location. These lectin-binding studies have allowed a comparison between glycoconjugate structures in metaplasia and those found in normal tissues. Glycoconjugates in columnar epithelial metaplasia demonstrated several interesting similarities and differences when compared with the corresponding normal tissues. Gastric-type Barrett's epithelium showed the same labeling pattern as was seen in normal gastric mucosa. This is not especially surprising since most of the biopsies with gastric-type epithelium were from the lower esophageal region or within 2 cm of it. This may not reflect metaplasia in all instances; it may reflect an imperfect or discrepant (squamo-columnar) histologic junction in relation to the location of the lower esophageal sphincter region.
The specialized type of epithelium differed from normal duodenal mucosa in that increased UEA, and s-WGA binding was seen throughout the metaplastic tissue compared with surface and crypt epithelium in the normal duodenum. In general the glycoconjugate structures expressed in metaplastic tissue more closely resembled those of normal rather than neoplastic tissues. Dysplasia is a morphological term which refers to tissue that is thought to have a defect in differentiation, and it is perhaps the earliest identifiable form of neoplasia. The presence of low grade dysplasia had no important effects on glycoconjugate expression in this study. This may reflect the difficulty in distinguishing low grade dysplasia from nondysplastic columnar metaplasia (i.e., ordinary Barrett's mucosa) (30) . However, a distinct change was seen in high grade dysplasia, in which the expression of several terminal carbohydrate structures, those bound by s-WGA, UEA1, PNA, and DBA, were not expressed in the surface epithelium. This was of particular interest because these carbohydrate structures were expressed in normal gastric epithelium, whereas binding sites for DBA and UEAI tended not to be expressed in the glycoconjugates of adenocarcinoma of the esophagus and stomach. This could be accounted for by a failure of terminal glycosylation in high grade dysplasia and carcinoma. However, the synthesis of a more complex carbohydrate structure not recognized by the lectins used in this study could produce similar results. In any event, the perturbation in terminal glycosylation patterns is first seen in high grade, rather than low grade, dysplasia. Detailed structural studies on glycoconjugates from these types of tissues will be necessary to unravel the mechanisms that underlie the change in glycoconjugate structure seen in neoplastic tissues.
It was of additional interest that UEA1 binding sites were consistently expressed in well-differentiated gastric adenocarcinoma but not in poorly differentiated gastric adenocarcinoma. DBA binding was not seen in either morphological variant of gastric cancer, which is consistent with previous reports of a deletion of blood group A activity in gastric carcinoma (31) . Poorly differentiated adenocarcinoma was characterized by a partial reduction of s-WGA and PNA binding sites as well. In fact, the progression from normal to fully malignant tissue was generally characterized by a stepwise deletion of terminal glycosylation structures in mucin-type glycoconjugates, an observation consistent with other recent reports (32, 33) .
In summary, a glycoconjugate profile has been defined for each distinct epithelial cell population in the stomach, duodenum, and columnar-lined esophagus (Barrett's esophagus). Glycoconjugate expression in epithelial metaplasia was found to resemble the structures expressed in normal tissues. Minor alterations in glycoconjugate expression were found in low grade dysplasia of the columnar-lined esophagus, however a restriction in the expression of glycoconjugates was seen in high grade dysplasia. Restricted glycoconjugate expression was also found in adenocarcinomas of the esophagus and stomach. These studies demonstrate that glycosylation of mucin-type glycoconjugates is preserved in epithelial metaplasia, but is aberrant in the settings of high grade dysplasia and cancer. Fluorescent lectin studies on tissue sections permit the detailed localization of glycoconjugates structures within different cell populations in normal, metaplastic, and neoplastic tissues. This experimental approach provides information on epithelial microdomains not generally available with techniques directed towards more complete biochemical characterization.
